Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2400034	奥妥珠单抗注射液	obinutuzumab	Injection	Biological Products	Supplementary Application	2024-02-19					view
JYSB2400022	奥妥珠单抗注射液	obinutuzumab	Injection	Biological Products	Supplementary Application	2024-02-01					view
JXSB2300101	奥妥珠单抗注射液	obinutuzumab	Injection	Biological Products(2.2)	Supplementary Application	2023-08-16					view
JXSL2200165	奥妥珠单抗注射液	obinutuzumab	Injection	Biological Products(2.2)	Import Drug Application	2022-09-15					view
JXSB2200102	奥妥珠单抗注射液	obinutuzumab	Injection	Biological Products(2.2)	Supplementary Application	2022-08-24					view
JXSB2200064	奥妥珠单抗注射液	obinutuzumab	Injection	Biological Products(2.2)	Supplementary Application	2022-06-03					view
JYSB2200008	奥妥珠单抗注射液	obinutuzumab	Injection	Biological Products	Supplementary Application	2022-01-18					view
JXSL2101130	奥妥珠单抗注射液	obinutuzumab	Injection	Biological Products(2.2)	Import Drug Application	2021-11-16					view
JXSB2101063	奥妥珠单抗注射液	obinutuzumab	Injection	Biological Products(2.2)	Supplementary Application	2021-09-26					view
JYSB2101079	奥妥珠单抗注射液	obinutuzumab	Injection	Biological Products	Supplementary Application	2021-07-08					view
JXSL2101044	奥妥珠单抗注射液	obinutuzumab	Injection	Biological Products(2.2)	Import Drug Application	2021-06-22					view
JXSL2000162	奥妥珠单抗注射液	obinutuzumab	Injection	Biological Products(2.2)	Import Drug Application	2020-09-27	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	In Review	2020-09-25	view
JYSB2000165	奥妥珠单抗注射液	obinutuzumab	Injection	Biological Products	Supplementary Application	2020-05-11	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	In Review	2020-05-10	view
JXSS1900059	奥妥珠单抗注射液	obinutuzumab	Injection	Biological Products	Import Drug Application	2019-09-28	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	In Review	2019-09-27	view